BD and Euroclone Announce Development and Global Distribution Agreement for Tests to Detect Emerging Sexually-Transmitted Pathogens
FRANKLIN LAKES, N.J. and SIZIANO, Italy, Sept. 20, 2017 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Euroclone (Euroclone Diagnostica Srl) today announced a development and global distribution agreement for molecular tests to detect emerging sexually-transmitted pathogens. According to the World Health Organization, more than 1 million... Read more